85. 特発性間質性肺炎 ［臨床試験数：514，薬物数：377（DrugBank：108），標的遺伝子数：97，標的パスウェイ数：204］
Searched query = "Idiopathic interstitial pneumonia", "IIPs", "Idiopathic pulmonary fibrosis", "IPF", "Usual interstitial pneumonia", "UIP", "Non-specific interstitial pneumonia", "NSIP", "Acute interstitial pneumonia", "AIP", "Diffuse alveolar damage", "DAD", "COP", "Organizing pneumonia", "OP", "Desquamative interstitial pneumonia", "DIP", "Respiratory bronchiolitis - associated interstitial lung disease", "RB-ILD", "Lymphocytic interstitial pneumonia", "LIP"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||JPRN-JapicCTI-163326||01/5/2016||22/07/2016||Phase III clinical study of ART-123 for the treatment of acute exacerbation of idiopathic pulmonary fibrosis||Phase III clinical study of ART-123 for the treatment of acute exacerbation of idiopathic pulmonary fibrosis||Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF)||Intervention name : ART-123|
INN of the intervention : thrombomodulin alfa
Dosage And administration of the intervention : 380 U/kg/day by intravenous drip infusion in addition to standard of care steroid therapy
Control intervention name : Placebo
Dosage And administration of the control intervention : Placebo by intravenous drip infusion in addition to standard of care steroid therapy
|ASAHI KASEI PHARMA CORPORATION||NULL||recruiting||40||85||BOTH||Phase 3||NULL|